Answers are grounded in this paper and cite their sources.
Benfotiamine may extend the treatment option for patients with diabetic polyneuropathy based on causal influence on impaired glucose metabolism. Further studies should confirm the positive experiences.
No takes yet. Share an insight, caveat, or question.
Stracke et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: